ICPMS-2030 Expanding solutions for elemental impurity analysis in pharmaceutical products

Article

 

 

Shimadzu has released its new ICPMS-2030 Inductively Coupled Plasma Mass Spectrometer. It meets the requirements of the ICH Q3D guidelines for elemental impurities in pharmaceutical products. The ICPMS-2030 satisfies these requirements with ppt level high sensitivity. This is achieved by the newly developed collision cell and the optimized internal structure. During the ICPMS-2030 European Launch Tour ("Critical Mass Tour") starting March 2016, the ICPMS-2030 can be seen at several exhibitions.


For more details please visit www.shimadzu.eu

 

Recent Videos
Lee Cronin, founder and CEO of Chemify
Drug Digest: Is Our Understanding of Stability Changing
Related Content